IRIS PubliCatt

Laurenti, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.119
EU - Europa 7.948
AS - Asia 2.977
OC - Oceania 159
AF - Africa 80
SA - Sud America 61
Continente sconosciuto - Info sul continente non disponibili 10
Totale 20.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.975
DE - Germania 2.208
SE - Svezia 1.677
CN - Cina 1.367
IT - Italia 1.285
SG - Singapore 826
UA - Ucraina 670
IE - Irlanda 524
FR - Francia 386
GB - Regno Unito 367
ID - Indonesia 324
RU - Federazione Russa 220
FI - Finlandia 193
IN - India 163
AU - Australia 132
CA - Canada 112
TR - Turchia 97
PL - Polonia 81
NL - Olanda 55
CI - Costa d'Avorio 42
BE - Belgio 40
HK - Hong Kong 36
JP - Giappone 35
ES - Italia 30
HU - Ungheria 27
NZ - Nuova Zelanda 27
IR - Iran 26
BR - Brasile 25
MX - Messico 25
CZ - Repubblica Ceca 24
RO - Romania 22
CH - Svizzera 20
AT - Austria 17
GR - Grecia 15
KR - Corea 15
AR - Argentina 12
EG - Egitto 12
PT - Portogallo 12
IL - Israele 11
TH - Thailandia 11
CL - Cile 10
VN - Vietnam 10
LT - Lituania 9
BG - Bulgaria 8
DZ - Algeria 8
HR - Croazia 8
NO - Norvegia 8
SA - Arabia Saudita 8
SK - Slovacchia (Repubblica Slovacca) 8
EU - Europa 6
MY - Malesia 6
ZA - Sudafrica 6
CO - Colombia 5
LB - Libano 5
NP - Nepal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
BZ - Belize 4
EE - Estonia 4
MA - Marocco 4
MD - Moldavia 4
MK - Macedonia 4
PE - Perù 4
PK - Pakistan 4
BY - Bielorussia 3
GE - Georgia 3
PH - Filippine 3
RS - Serbia 3
SI - Slovenia 3
TW - Taiwan 3
BD - Bangladesh 2
CM - Camerun 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
ET - Etiopia 2
GH - Ghana 2
IQ - Iraq 2
JO - Giordania 2
LI - Liechtenstein 2
QA - Qatar 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CY - Cipro 1
IS - Islanda 1
KE - Kenya 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
PR - Porto Rico 1
SC - Seychelles 1
UZ - Uzbekistan 1
Totale 20.354
Salva come PNG Salva come JPEG
Città #
Chandler 1.400
Ashburn 639
Singapore 630
Dublin 508
Jacksonville 412
San Mateo 354
Jakarta 315
Dearborn 303
Nanjing 299
Wilmington 266
Beijing 238
Milan 230
Ann Arbor 215
New York 192
Boston 176
Florence 176
Cattolica 170
Woodbridge 144
Moscow 140
Redwood City 140
Houston 132
Lawrence 130
Princeton 127
Rome 122
Nanchang 121
Nürnberg 121
Seattle 117
Los Angeles 116
Munich 106
Redmond 106
Marseille 105
Lancaster 103
Fairfield 96
Izmir 82
Kunming 80
Bremen 79
Chicago 64
Mountain View 56
Boardman 54
Shenyang 54
Warsaw 54
Norwalk 49
Washington 45
Abidjan 42
Zhengzhou 42
Tianjin 41
Hefei 38
Pune 38
Hebei 37
Brussels 36
Helsinki 36
London 36
Cambridge 34
Jiaxing 34
Guangzhou 33
Hangzhou 33
Changsha 31
Auburn Hills 30
Hong Kong 28
Phoenix 28
Sydney 28
Philadelphia 26
San Francisco 26
Shanghai 26
Toronto 26
Minneapolis 24
Melbourne 23
Portland 23
Adelaide 22
Brisbane 22
Leawood 22
Fremont 21
Santa Clara 21
University Park 21
Busto Arsizio 20
Detroit 20
Augusta 18
Jinan 18
Lanzhou 17
Albany 16
Brooklyn 16
Changchun 16
Brno 15
Budapest 15
Bologna 14
Padova 14
San Diego 14
Amsterdam 13
Frankfurt am Main 13
Turin 13
Auckland 12
Falls Church 12
Atlanta 11
Buffalo 11
Lappeenranta 11
Ottawa 11
Seoul 11
Chengdu 10
Cincinnati 10
Paris 10
Totale 10.355
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.300
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 593
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 355
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 305
Factors associated with mortality in bacteremic patients with hematologic malignancies. 300
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 285
Factors associated with mortality in bacteremic patients with hematologic malignancies. 166
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 149
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 148
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 147
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 144
Correlation between paraproteinaemia and viral reactivation after allo-SCT 142
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 138
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 138
Evaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma. A pilot study. 135
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 134
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 128
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 128
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 117
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 117
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 116
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 115
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 115
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 111
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 110
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 108
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 106
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 105
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 105
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 104
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 103
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 103
Guillain-Barre' syndrome following Varicella zoster reactivation in Chronic Lymphocytic Leukemia treated with fludarabine 103
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 103
Hyperleukocytosis and leukostasis: management of a medical emergency 103
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 102
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 102
Hyperleukocytosis and leukostasis: management of a medical emergency 102
Work related acute leukemia and mucor mycosis in a boat-builder 101
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 100
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome 99
Neurologic improvement after peripheral blood stem cell transplantation in poems 98
Usefulness of F-18 FDG PET/CT in the follow-up of POEMS syndrome after autologous peripheral blood stem cell transplantation 96
Clinical and pathological heterogeneity in a series of 31 patients with IgM-related neuropathy 96
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 96
Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström's macroglobulinaemia. 95
Mycosis fungoides as a cause of severe obstructive sleep apnea 94
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 94
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 92
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 92
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 91
Evaluation of intraorbital injection of rituximab for treatment of primary ocular adnexal lymphoma: a pilot study 90
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 89
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease 88
TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients 88
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 87
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 87
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 87
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 86
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome 85
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 84
The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia 83
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 83
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification 83
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 81
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage 79
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 79
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia 78
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 78
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 76
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 76
Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group 74
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 73
Two types of BCR interactions are positively selected during leukemia development in the Eμ-TCL1 transgenic mouse model of CLL 72
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 72
Long-term outcomes of primary ocular adnexal lymphoma treatment with intraorbital rituximab injections. 72
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 72
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells 71
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience 70
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia 70
Chronic Lymphocitic Leukaemia: Census of Patients Treated in Italian Haematology Units 69
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 69
The Syk kinase as a therapeutic target in leukemia and lymphoma 68
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 68
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 68
Unrelated cord blood transplantation and post-transplant cyclophosphamide 67
Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease 66
High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders 66
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 66
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. 66
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments. 66
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 66
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia. 65
Unrelated cord blood transplantation and post-transplant cyclophosphamide 64
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 63
Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia 63
Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia 63
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 63
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 62
Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia 62
Totale 12.852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.581
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.569 0 0 0 0 204 307 242 118 133 180 213 172
2020/20211.552 60 167 50 143 220 115 144 38 193 65 316 41
2021/20222.255 183 130 131 152 168 65 38 322 107 126 426 407
2022/20234.423 631 627 350 544 331 553 197 308 500 87 215 80
2023/20244.053 126 732 201 777 226 502 196 110 133 233 389 428
2024/20251.857 378 276 506 247 450 0 0 0 0 0 0 0
Totale 20.746